Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 5Urinary Bladder Neoplasms 2Male Urogenital Diseases 2Smoking Cessation 1Pancreatic Neoplasms 1Pain, Postoperative 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lung Neoplasms 1Lung Cancer Prevention 1Leiomyoma 1Inflammatory Bowel Diseases 1Duodenal Neoplasms 1Diverticulitis 1Colonic Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

telapristone acetate 10ulipristal 3asoprisnil 3vilaprisan 2estradiol, norethindrone drug combination 2elagolix 2Norethindrone Acetate 2Mifepristone 2Lidocaine 2Leuprolide 2Estradiol 2ulipristal acetate 1relugolix 1pirfenidone 1epigallocatechin gallate 1Tea 1Sugars 1Simvastatin 1Ropivacaine 1Progesterone 1Morphine 1Methadone 1Injections, Subcutaneous 1Embolization, Therapeutic 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leiomyoma × Tea × Clear all
NCT01311869 2013-10-24

Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids

Meharry Medical College

Phase 2 Terminated
43 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡